iiinova — where your digital self keeps evolving

Sofie Deschoemaeker

@sofiedeschoemaeker.bsky.social

113 followers 403 following 6 posts

Post-doctoral scientist @Laoui Team @VUB @VIBLifeSciences passionate about cancer immunology by day and travelling and good food by night :-)

Posts Replies Media

Reposted by Sofie Deschoemaeker

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 07/10/2025

The Laoui Lab will be well represented at the Tumor Heterogeneity, Plasticity and Therapy (3rd edition) conference #THPT25! Join us to hear more about therapy resistence in #cancer from Anna Obenauf @obenaufa.bsky.social Submit your abstract by the 8th of October on vibbio.tech/THPT25

053

Sofie Deschoemaeker @sofiedeschoemaeker.bsky.social · 23/09/2025

Glad to have been part of this exciting project!

010

Sofie Deschoemaeker @sofiedeschoemaeker.bsky.social · 07/05/2025

The coming 3 days, I’m conference reporter at the Immune Niches in Cancer and Inflammation conference in Bruges #INCI25 😀 Follow @laouimmunology.bsky.social, our lab accounts for the highlights!

030

Sofie Deschoemaeker @sofiedeschoemaeker.bsky.social · 22/04/2025

Join us in Bruges at the #INCI25 to discuss more about novel #celltherapies to treat #cancer Last chance to register! 🔗 vibbio.tech/INCI25

vibbio.tech

Immune Niches in Cancer & Inflammation

7-9 May 2025, Bruges, Belgium Organized in partnership with Cell Press

010

Sofie Deschoemaeker @sofiedeschoemaeker.bsky.social · 08/04/2025

Don't forget to register for #INCI25 at vibbio.tech/INCI25 ⏰Deadline: 23rd of April

vibbio.tech

Immune Niches in Cancer & Inflammation

7-9 May 2025, Bruges, Belgium Organized in partnership with Cell Press

020

Reposted by Sofie Deschoemaeker

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 21/03/2025

Interested in hearing more about how our 🕐internal clock🕐 can influence anti-tumor immunity? Christoph Scheiermann will explain all about it at the Immune Niches in Cancer and Inflammation conference #INCI25 ! Don’t miss the early bird registration! 🚨Deadline: 26th of March vibbio.tech/INCI25

021

Reposted by Sofie Deschoemaeker

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 13/03/2025

🚨Early Bird registration deadline for #INCI25 is approaching Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃 @miriammerad.bsky.social vibbio.tech/INCI25

042

Sofie Deschoemaeker @sofiedeschoemaeker.bsky.social · 25/02/2025

My abstract is submitted already, don't forget to submit yours to join us at #INCI25 in Bruges to discuss how dendritic cells can serve as cancer therapy 😀

042

Reposted by Sofie Deschoemaeker

VIB Training & Conferences @vibtrainconf.bsky.social · 25/02/2025

⌛ Only three days left until the #INCI25 abstract deadline! Submit your #cancerbiology or #inflammation research by Friday, February 28. Present your research on stage or in poster sessions to win the Cell Press Poster Prize🏆. Upload it to vibbio.tech/4gYySvZ

065

Sofie Deschoemaeker @sofiedeschoemaeker.bsky.social · 19/02/2025

Join us and discover our research at #INCI25 in the wonderfull Bruges ! Submit your abstract by the 28th of February at vibbio.tech/INCI25

vibbio.tech

Immune Niches in Cancer & Inflammation

7-9 May 2025, Bruges, Belgium Organized in partnership with Cell Press

040

Reposted by Sofie Deschoemaeker

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 11/02/2025

Today is #womaninscience day! For all the ladies out there that doubt if science is something for them, yes it is! #proudoftheteam @vubrussel @viblifesciences.bsky.social

031

Reposted by Sofie Deschoemaeker

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 18/01/2025

Excited to share our latest work in @NatureComms ! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine & @bruno_de_geest. Read here: rdcu.be/d2zQ7

rdcu.be

Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity

Nature Communications - Local delivery of mRNA-based immunotherapy represents an option for cancer therapy. Here the authors report that intratumoral delivery of lipid nanoparticle-formulated mRNA...

041